Summary by Moomoo AI
Wing Cheong Biopharmaceuticals (Yantai) Co., Ltd. filed with Hong Kong Trading and Settlement Limited on April 8, 2024 its latest Securities Changes Monthly Report, reporting stock changes for the year ended March 31, 2024. The report showed that the Company's number of Class H ordinary shares listed on the Hong Kong Stock Exchange did not decrease during the month, amounting to 189,581,239 shares with a face value of RMB 1 per share. The share of Class A ordinary shares listed on the Shanghai Stock Exchange did not increase, amounting to 354,750,844 shares. In addition, under the A share incentive plan for 2022 and 2023, the company may issue new Class A ordinary shares totaling 2,498,330 shares. The Company confirms that all securities issues have been approved by the Board of Directors and are in compliance with relevant legal requirements.